to invasive surgical procedures, such as spinal fusion. For patients with symptomatic degenerative lumbar spondylolisthesis, the use of spinal fusion with instrumentation can offer better outcomes than those obtained with surgical decompression alone; however, results can vary depending on a patient's history, age, comorbidities, and current disease-related symptoms. 11, 21, 26 For patients with spinal stenosis without spondylolisthesis, spinal fusion is often performed after decompression to address concomitant low-back pain from facet arthrosis or degenerative disc disease. Given the lack of consensus regarding the best treatment algorithm for these disorders, there is a continued need to develop surgical strategies and medical devices to improve both intraoperative and postoperative treatment and recovery. Particularly because of the wide variety of therapeutic options available, it is important to understand the burden of current surgical procedures on the health care system in terms of perioperative complications and health care costs. Therefore, our purpose in conducting this study was to quantify the perioperative outcomes, complications, and costs associated with posterolateral lumbar spinal fusion (PSF) among patients with lumbar spinal stenosis (LSS) and spondylolisthesis by using a national Medicare claims database.
Methods
A 5% systematic sample of the Medicare claims data (2005-2009) was used to identify patients who had undergone PSF for LSS and/or spondylolisthesis between 2006 and 2007 and to track their outcomes. This sample contained claims data for approximately 2.5 million Medicare beneficiaries in the US. From this data set, we identified patients by using the Current Procedural Terminology (CPT) code 22612 and LSS and spondylolisthesis by using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes 724.02, 738.4, and 756.12. To verify that patients did not have 360° fusion, we excluded PSFs that were coded concurrently with an interbody device (CPT code 22851) or anterior spine fusion (CPT code 22558).
To limit the amount of incomplete health and claims history, patients were excluded from the study if they were non-US residents or if they were not enrolled in Medicare Parts A (hospital providers) and B (physician providers). To further limit the confounding effects, we also excluded patients who did not have a minimum of 2 years of postoperative follow-up or a complete claims history in the full 12 months prior to PSF, as well as any patients who had undergone any spine surgery (for example, lumbar spine fusion, lumbar total disc replacement, laminectomy or laminotomy, or any operation involving interspinous devices) within 12 months prior to the PSF. Such patients were identified based on the presence of the corresponding ICD-9-CM or CPT codes from the claims records (Table 1) . Medicare beneficiaries younger than 65 years of age were included in the study to provide an overall perspective of the health care burden for PSF patients, even though those younger than 65 years have end-stage renal disease or physical disabilities. Patient age was taken into consideration to account for these medical conditions, as was the Charlson Comorbidity Index (CCI). Patients who had undergone multilevel fusion were identified as those with CPT code 22614, whereas those who had undergone posterior instrumentation were identified with CPT codes 22840, 22842, 22843, or 22844.
The length of stay for the index PSF surgery was calculated from the Medicare claims data. Discharge status-that is, discharge to home, skilled nursing facility, rehabilitation facility, or home health services-was also examined. Patients were followed up for 2 years to determine the incidence of postoperative complications, which included spine reoperation, infection, lumbosacral spinal cord injury, lumbosacral nerve root injury, dural tear and/or puncture, pneumonia, pulmonary embolism, myocardial infarction, mechanical complication, hemorrhage and/or hematoma, heterotopic ossification, lumbar spine fracture, postlaminectomy syndrome, wound infection, urinary tract infection, nonunion or malunion, removal of hardware, and readmission for associated complications. These complications were identified based on the presence of the corresponding ICD-9-CM diagnosis codes and ICD-9-CM or CPT procedure codes from the claims records ( Table 2 ). The number of epidural steroid injections in the 12 months before and the 2 years after PSF, as well as the incidence of postoperative electrical stimulation use and blood transfusion, was also assessed. Treatment costs from a payer's perspective, defined in our study as Medicare's actual reimbursement and/or payment (adjusted to May 2011 dollars 7 ), were also evaluated for the 24 months of follow-up. Payment by the Medicare trust fund (that is, cost to payer) for care associated with these patients was compiled from the Medicare claims records.
Outcomes and treatment costs within the cohort were compared using logistic regression, adjusting for patient sex, age, census region (Northeast, Midwest, South, West), comorbidities (CCI score), race, socioeconomic status (Medicare buy-in status), levels fused (single, multiple), and primary/principal diagnosis (stenosis, spondylolisthesis, others). The Medicare buy-in status indicated patients whose Medicare premiums and deductibles were subsidized by the state because of their financial status and was used as a proxy for the patient's socioeconomic status. To account for the general health status of each patient, the composite CCI (Dartmouth-Manitoba version 10 ), a metric that predicts the risk of 10-year mortality, was calculated. All disease diagnoses in a 12-month period before the index PSF were compiled from the Medicare claims. The CCI algorithm utilizes 19 categories of diseases based on the diagnosis and surgeries indicated in a patient. A "weight" with values of 1, 2, 3, or 6 is assigned to each category, and the final index is a composite value representing the overall degree of comorbidity. For this analysis, the CCI values were grouped into previously established categories:
19 0, none; 1-2, low; 3-4, moderate; and ≥ 5, high. Statistical significance was defined at p < 0.05.
Results
In 2006 and 2007, approximately 90% of 106,365 patients with a diagnosis of stenosis and/or spondylolis-thesis did not receive operative care (fusion, decompression, laminectomy, laminotomy, or discectomy). After applying inclusion and exclusion criteria, we obtained a final cohort of 1672 PSF patients for this study. Lumbar spinal stenosis and spondylolisthesis were the primary diagnoses for 58.7% and 18.9% of the patients, respectively, and were secondary diagnoses for the remaining patients. Of the 1672 PSF patients, 50.7% had LSS only, 10.2% had spondylolisthesis only, and 39.1% had both LSS and spondylolisthesis. Instrumented fusion was performed in 69.8% of the patients, and multilevel fusion was performed in 55.8%. The patients had received an average of 2.3 ± 2.9 epidural injections in the 12 months prior to the PSF. The average number of preoperative epidural injections increased from 1.8 for those under 65 years of age to 3.2 for those 85 years and older. Two-thirds of the patients (66.7%) were female, and the majority of patients were white (91.7% white, 6.0% black, 2.4% others). The distribution of patients by CCI scores of 0, 1-2, 3-4, and ≥ 5 was 31.2%, 49.0%, 15.4%, and 4.4%, respectively. The largest group of patients was from the South (40.2%), followed by the Midwest (31.2%), West (14.5%), and Northeast (14.1%).
For the overall cohort, the average age was 71.4 ± 7.9 years (range 34-91 years), and patients younger than 65 years accounted for 11.5% of the study cohort ( Fig.  1 ). The average length of stay (LOS) was 4.6 ± 3.2 days (Fig. 2 upper) . Patients were routinely discharged to home, (42.2%) or discharged to a skilled nursing facility (18.0%), home health service (19.4%), or rehabilitation facility (17.2%; Fig. 3 upper) . Length of stay was significantly associated with age (p = 0.001), with patients 65 years or older tending to have longer hospital stays (Fig. 2 lower) . Discharge status was also significantly as- (Fig. 3 lower) .
Length of stay and discharge status were not significantly associated with primary diagnosis. At the 3-month, 1-year, and 2-year follow-ups, the incidences of spine reoperation were 10.9%, 13.3%, and 16.9%, respectively, while the combined incidences of spine reoperation and/or epidural injections were 18.2%, 27.0%, and 36.2%, respectively ( Table 3 ). The incidence of readmission for any complication was 11.1% at 3 months, 17.5% at 1 year, and 24.9% at 2 years. Spine reoperation and/or epidural injections (p = 0.004) and readmission for complications (p = 0.011) were significantly associated with age at the 2-year follow-up, tending to be lower for those with an age ≥ 65 years (35.2% vs 43.8% for reoperation and/or epidural injections, 24.7% vs 27.1% for readmission).
The overall average payment for all covered health care for patients who underwent PSF was $36,230 ± $17,020, $46,840 ± $31,350, and $61,610 ± $46,580, respectively, at 3 months, 1 year, and 2 years after surgery and corresponded to an overall cost to Medicare of $60.6 million, $78.3 million, and $103.0 million for treating these 1672 patients.
Discussion
Analyzing the 5% Medicare data, we found that only a small proportion of patients with LSS and spondylolisthesis underwent fusion surgery. The relatively low rates of surgical treatment were also somewhat surprising, especially given that previous clinical trials have generally shown improved outcomes when patients are treated surgically rather than nonsurgically, 26 especially in those with LSS 28 and spondylolisthesis. 27 Furthermore, authors of another study reported that the rates of complex fusion procedures had increased more than 10-fold in patients with a primary diagnosis of spinal stenosis in the period from 2002 to 2007, although they also noted a slight decrease in the corresponding rate of simple fusion. 12 Given the more invasive nature of fusion surgery, patients who undergo such procedures are more likely to require added postsurgical care. Approximately half of the patients in our study were discharged in 3-4 days (49.1% total). However, after further analyzing the patients by age, we found that older patients were more likely to require longer LOSs than the younger patients (p = 0.001, age < 65 vs ≥ 65 years). In addition, younger patients were also more likely to be routinely discharged, whereas older ones were more likely to be discharged to skilled nursing and/or rehabilitation facilities. Taken together, these data suggest that older patients require more extensive health care and therefore incur greater costs to help them recover from PSF.
In addition to the surgical recovery time, perioperative and postoperative complications can result from surgical treatment. In our analysis, we found that at the 2-year follow-up, urinary tract infection, spine reoperation and/ or epidural injections, epidural injections, postlaminectomy syndrome, and readmission occurred in at least 1 of 4 patients. Note, however, that some of the reoperations within the first 3 months may have been planned and/or part of staged procedures and perhaps unrelated to complications. We did attempt to account for this factor by limiting reoperations to only those with any corresponding diagnoses of infection, spinal cord injury, nerve root injury, dural tear, mechanical complications, hemorrhage/ hematoma/seroma, spine fracture, postlaminectomy syndrome, wound infection, nonunion/malunion, complications due to internal orthopedic device/implant, cauda equina syndrome, acquired kyphosis postlaminectomy, or closed thoracolumbar vertebral dislocation.
Other reports on PSF have also discussed some of the complications we found. For example, revision surgery rates of 9.3% and pseudarthrosis rates of 4.65% have been documented but only after a follow-up of approximately 5 years. 1 In another study, Cheng et al. 4 reported a relatively higher nonunion rate of 19.7% in a patient cohort 4 years after PSF. Hardware removal rates of up to 32% have also been described. 5, 9, 15 Regarding infection, in a multicenter randomized study comparing 2-year outcomes in patients undergoing noninstrumented and instrumented posterolateral fusion, the latter patients had a higher infection rate of 7.4%, compared with 1.4% in the former. 15 The instrumented patients also had a higher rate of nerve root pain (4.4% vs 0%). No instances of minor dural tears were found in either cohort. Moreover, relatively low dural tear rates of 1.6% were reported in a cohort of PSF patients with severe, chronic low-back pain from spondylolisthesis Grades 1 and 2 or from primary or secondary degenerative segmental instability. 25 In contrast, in our study we found a higher rate of dural tears of approximately 6% at 2 years post-PSF.
It is notable that a relatively large number of the PSF patients in our study continued to receive epidural injections, but it is unclear if these injections were intended to address the previously treated spine levels or adjacent levels. Epidural injections are an area for further investigation into whether improvements can be made in terms of effective delivery and lowered costs of surgical care, since some researchers have noted that limited data suggest that epidural steroid injections are effective for improving selected short-term outcomes in some patients with lumbar spinal stenosis, 2 whereas others have questioned whether the benefits outweigh the risks. 13 Our study also demonstrated a readmission rate of 11.1% at 3 months for the complications listed in Table 3 , which is another potential area for improving delivery of care in patients who undergo PSF. As a result of surgical complications and postoperative rehabilitation and treatment, the burden of care for our patient cohort averaged $61,610 ± $46,580 at 2 years after PSF and corresponded to an overall 2-year cost to Medicare of $103.0 million for treating these patients, which extrapolates to an estimated $2 billion when considering the entire Medicare population.
Lumbar spine fusion has been considered the standard of care for degenerative spondylolisthesis, but fusion is also commonly performed in patients with predominant low-back pain and spinal stenosis without spondylolisthesis. 8, 16 More recently, clinicians have suggested that motion-preserving interlaminar stabilization could be an effective treatment for patients with degenerative spondylolisthesis or stenosis. 8, 20, 23 As part of a prospective, randomized, multicenter clinical trial comparing outcomes of PSF and interlaminar stabilization, a subset of 150 patients with Grade 1 spondylolisthesis were followed up for a minimum of 2 years. 8 Interlaminar stabilization was found to be safe and as efficacious as PSF with similar clinical outcomes, while requiring fewer health care resources because of reduced LOSs, operative times, and blood loss. The PSF patients were also noted to have significantly increased superior-and inferior-level angulation and translation, as compared with the interlaminar stabilization patients who experienced no significant adjacentor index-level radiographic changes. These changes in the PSF group could lead to higher risks of adjacent-segment degeneration. In a case series of 22 patients who had undergone a combination of unilateral microdecompression and interspinous distraction device insertion for spinal stenosis, significant improvements in the visual analog scale score and Oswestry Disability Index were observed. 20 No major complications were encountered in this cohort. In a 2-year study of patients with spinal stenosis and neurogenic claudication, patients were randomized to decompressive surgery or implantation of the X-STOP interspinous spacer. 24 Although similar results were achieved in both groups, the investigators reported a higher number of reoperations in the X-STOP group. In another study with a follow-up to 2 years, laminectomy was a more costeffective treatment strategy for patients with lumbar stenosis than X-STOP, with conservative treatment being the least cost-effective. 3 At this time, studies of interlaminar stabilization have relatively short follow-ups, and thus it is unknown whether the improvement in outcomes will be demonstrated with longer-term data.
Our analysis of the Medicare PSF patient population had several limitations. Although we were able to control for comorbid conditions and exclude patients who had undergone a previous surgery, we were unable to analyze either the specific types of instrumentation used in PSF or the number of levels treated. In addition, we were unable to ascertain the accuracy or reliability of the coding of various procedures and diagnoses since we used an administrative claims database, although the Medicare 5% data set still represents an important and widely used resource for research. We were also unable to evaluate functional outcomes, such as the Oswestry Disability Index and pain index, because we used the administrative claims data. Although lumbar spine fusion, which is considered the standard of care for degenerative spondylolisthesis, was the focus of our study, patients can also undergo other surgeries, such as decompression and/or laminectomy. It is unclear to what extent the costs and outcomes may differ between our PSF cohort and a casecontrolled decompression/laminectomy cohort, although previous research 18 has suggested that patients with lumbar spondylolisthesis who undergo decompressive laminectomy and spinal arthrodesis have lower reoperation rates but higher overall costs than patients treated with laminectomy alone. Further research may provide additional insights into the costs and outcomes for various treatment modalities. Our cost analysis was limited to direct costs and did not consider indirect costs given the lack of such data in the administrative claims database. Despite these limitations, the national scope of the Medicare database presents a "big picture" view of complications associated with PSF and is an unmatched resource, despite the inability to explore patient-reported or functional outcomes.
Conclusions
Our analysis of a subset of Medicare patients treated for LSS and/or spondylolisthesis via PSF suggested that older patients may require more extensive postoperative care and may be more predisposed to certain types of surgical complications. As the rate of surgery increases and as surgical procedures and medical technologies become more complicated, medical costs will continue to increase and place a significant burden on Medicare. Therefore, it is important to continue studying outcomes to better understand which subsets of patients respond most favorably to specific types of surgery to facilitate recovery and minimize costs to both the patient and the health care system. Our data also highlighted several potential areas in which improvements can be made in the effective delivery and lowered cost of surgical care for patients with spinal stenosis and spondylolisthesis.
